SK12199A3 - Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition - Google Patents

Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition Download PDF

Info

Publication number
SK12199A3
SK12199A3 SK121-99A SK12199A SK12199A3 SK 12199 A3 SK12199 A3 SK 12199A3 SK 12199 A SK12199 A SK 12199A SK 12199 A3 SK12199 A3 SK 12199A3
Authority
SK
Slovakia
Prior art keywords
oligosaccharide
oligosaccharides
elastin
cells
derivatives
Prior art date
Application number
SK121-99A
Other languages
English (en)
Slovak (sk)
Inventor
Ladislas Robert
Alexandre Robert
Dominique Castelli
Original Assignee
Roc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roc Sa filed Critical Roc Sa
Publication of SK12199A3 publication Critical patent/SK12199A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK121-99A 1996-07-31 1997-07-30 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition SK12199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609649A FR2751876B1 (fr) 1996-07-31 1996-07-31 Utilisation d'un oligosaccharide comme immunomodulateur, composition dermato-cosmetique et methode de traitement cosmetique
PCT/IB1997/000951 WO1998004270A1 (en) 1996-07-31 1997-07-30 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition

Publications (1)

Publication Number Publication Date
SK12199A3 true SK12199A3 (en) 2000-01-18

Family

ID=9494678

Family Applications (1)

Application Number Title Priority Date Filing Date
SK121-99A SK12199A3 (en) 1996-07-31 1997-07-30 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition

Country Status (15)

Country Link
EP (1) EP0954322A1 (cs)
JP (1) JP2000516591A (cs)
KR (1) KR20000029754A (cs)
CN (1) CN1228705A (cs)
AU (1) AU3457697A (cs)
BR (1) BR9710630A (cs)
CA (1) CA2262564A1 (cs)
CZ (1) CZ29599A3 (cs)
FR (1) FR2751876B1 (cs)
HU (1) HUP9903904A3 (cs)
NZ (1) NZ333985A (cs)
PL (1) PL331478A1 (cs)
RU (1) RU99104398A (cs)
SK (1) SK12199A3 (cs)
WO (1) WO1998004270A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US20060234980A1 (en) * 2002-05-31 2006-10-19 Hiroyuki Hashimoto Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
DK1721612T3 (da) * 2003-10-24 2009-06-02 Nutricia Nv Immunmodulerende oligosaccharider
JP2005281298A (ja) * 2004-03-04 2005-10-13 Fancl Corp メリビオースを有効成分とするｔ細胞免疫調節剤
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US20090163427A1 (en) * 2006-04-10 2009-06-25 Aleksander Vladimirovich Dikovskiy Pharmaceutical Composition of Enterosorbent and Prebiotics, Dosage Forms, and the Method for Prevention and Treatment of Gastrointestinal Disorders
GB0915315D0 (en) 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
GB2500585A (en) 2012-03-23 2013-10-02 Univ Manchester Use of oligosaccharides to reduce skin pigmentation
EP3060222A4 (en) * 2013-10-25 2017-07-05 Red Pinnace Limited Dietary regime for treatment of acne and other inflammatory skin conditions
US11328621B2 (en) 2013-10-25 2022-05-10 Red Pinnace Limited Dietary regime for treatment of acne and other inflammatory skin conditions
KR101689877B1 (ko) 2014-08-28 2016-12-26 (주)셀아이콘랩 아토피 개선용 화장료 조성물
KR101689875B1 (ko) 2014-08-28 2016-12-26 (주)셀아이콘랩 펩타이드와 아미노산의 혼합물을 함유하는 아토피 개선용 화장료 조성물
KR102046566B1 (ko) 2018-08-09 2019-11-19 박정혜 피부 가려움 개선용 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545087B1 (fr) * 1983-04-29 1985-12-27 Malte Oeuvres Hospit Fses Ordr Nouveaux derives glucidiques du 5-hydroxytryptophane, obtention et application comme medicaments
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
CA2118405A1 (en) * 1992-05-26 1993-09-12 Robert Maurice Ippolito Immunosuppressive and tolerogenic modified lewisc and lacnac compounds

Also Published As

Publication number Publication date
WO1998004270A1 (en) 1998-02-05
NZ333985A (en) 2000-09-29
CN1228705A (zh) 1999-09-15
AU3457697A (en) 1998-02-20
FR2751876A1 (fr) 1998-02-06
HUP9903904A2 (hu) 2000-04-28
CZ29599A3 (cs) 1999-06-16
EP0954322A1 (en) 1999-11-10
BR9710630A (pt) 2000-01-11
KR20000029754A (ko) 2000-05-25
CA2262564A1 (en) 1998-02-05
RU99104398A (ru) 2001-02-20
JP2000516591A (ja) 2000-12-12
FR2751876B1 (fr) 1998-12-31
HUP9903904A3 (en) 2000-05-29
PL331478A1 (en) 1999-07-19

Similar Documents

Publication Publication Date Title
Brattig et al. Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes
SK12199A3 (en) Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition
Goodwin Immunologic effects of nonsteroidal anti-inflammatory drugs
JPH11501284A (ja) アポトーシスを阻害する組成物、その組成物の精製方法およびその使用
US20080194476A1 (en) Medicament Comprising A Peptide Extract Of Avocado, Which Is Intended For The Treatment And Prevention Of Illnesses That Are Linked To An Immune System Deficiency
KR20190128146A (ko) 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부염 개선 용도
EP2311474A2 (en) Antioxidant, anti-inflammatory, or anti-aging composition containing a plant stem cell line derived from taxus cambium or procambium as an active ingredient
JP2002255777A (ja) 局所の化粧組成物
Kim et al. Therapeutic potential of gamma-irradiated resveratrol in ulcerative colitis via the anti-inflammatory activity and differentiation of tolerogenic dendritic cells
Kaplan Recent advances in cytokine therapy in leprosy
EP1962872B1 (en) Compositions and methods for modulating an immune response
Rosenkranz et al. 10. Immunobiology and Hematology of Zinc
EA000974B1 (ru) Применение экстракта гинкго двудольного для изготовления композиции топического использования, обладающей иммуномодулирующей активностью, и способ косметического ухода за сверхчувствительной кожей с его использованием
EP4081246B1 (en) Composition for treating or preventing an allergy or allergic reaction
Crowell et al. Hyperoxic suppression of Fc-gamma receptor-mediated phagocytosis by isolated murine pulmonary macrophages.
APEH et al. Significance of crude and degummed Citrullus lanatus seed oil on inflammatory cytokines in experimental infection induced by Candida albicans
Hallam et al. Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids.
KR101893886B1 (ko) 자가 면역 질환의 예방 또는 치료용 약학적 조성물 및 그 제조방법
KR101477552B1 (ko) 유제놀 유도체를 함유하는 아토피성 피부염의 치료용 약제학적 조성물 및 그 제조방법
Coble et al. Histamine release from mast cells during phagocytosis and interaction with activated neutrophils
Wiedermann et al. Immunorestoration in children with recurrent respiratory infections treated with Isoprinosine
EP3578187A1 (en) Pharmaceutical composition for preventing or treating hypersensitivity immune disease, and method for producing same
Cruchaud et al. The functions of human monocytes in normal subjects and in disorders associated with immune deficiency
Hunninghake et al. Suppression of the generation of human Con A-induced cytotoxic effector cells by Con A-activated suppressor cells
EP4349342A1 (en) Composition for immunosuppression comprising l-ahg